| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.6M | +34.9% |
| SG&A Expense | $6.2M | -3.0% |
| Operating Income | -$16.8M | -18.0% |
| Income Tax | $0 | — |
| Net Income | $2.8M | +121.0% |
| EPS (Basic) | $0.11 | +110.3% |
| EPS (Diluted) | $0.11 | +110.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.3M | +5.5% |
| Short-term Investments | $33K | +2.1% |
| Current Assets | $18.9M | +38.9% |
| Total Assets | $18.9M | +38.9% |
| Current Liabilities | $2.2M | -76.3% |
| Total Liabilities | $2.4M | -75.4% |
| Stockholders' Equity | $16.5M | +339.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.2M | -150.7% |
| Investing Cash Flow | -$693 | +48.6% |
| Financing Cash Flow | $27.9M | +57.1% |